Remove 2016 Remove Contracts Remove Marketing Remove Settlement
article thumbnail

REMICADE Antitrust Settlement Receives Final Approval

LexBlog IP

alleging that they engaged in anticompetitive conduct relating to the sale and marketing of J&J’s REMICADE (infliximab). The court preliminarily approved the settlement in August 2022. The post REMICADE Antitrust Settlement Receives Final Approval appeared first on Big Molecule Watch. million in expenses.

article thumbnail

adult venue's insurer did not successfully exclude ads from ad injury coverage

43(B)log

Princeton insured Wonderland from 2016-2018 (with a broad exclusion for defamation, invasion of privacy, and various forms of advertising injury in the second year called the Exhibitions and Related Marketing Exclusion), and agreed to defend the club but reserved the right to deny insurance coverage. Houston, Inc., 4th 274 (5th Cir.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Year in Review: Top Legal Developments of 2023

LexBlog IP

As we settle into 2024, we reflect on the significant legal developments of 2023 that hold potential impact on the biologics and biosimilars market. That IPR was terminated in August in view of a settlement agreement and before there was any decision on institution. That petition is pending. million in expenses.

article thumbnail

NFL Franchise Controversies

JIPEL Copyright Blog

In 2016, the St. The policy requires franchise owners to engage in “good faith” efforts to remain in their current market. As the NFL and its franchise owners continue to exhaust avenues to avoid litigation and discovery, the January 10, 2022 trial date approaches, and the likelihood of a settlement in this case increases.

article thumbnail

The Conundrum Regarding Security Cheques: Culpability And Consequences As Per Ni Act

IP and Legal Filings

The Court held that when the parties to the suit entered into a contract with a clause regarding the security cheque, there was no subsisting liability or debt which is why the contract itself makes it clear that the cheque had to be handed over as a security. 867 of 2016 [xii] Criminal Appeal Nos.

article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

Yet 2020 saw a slowdown in biosimilar activity with the lowest number of annual biosimilar approvals since 2016 and fewer product launches than 2019—as well as a decrease in district court litigation and post-grant proceedings. No earlier than July 31, 2023 per settlement. No earlier than November 20, 2023 per settlement. .

article thumbnail

Global Advertising Lawyers Alliance (GALA) Webinar – “Hot Topics in Advertising Law in North America”

43(B)log

Teami ($15 million settlement, all but $1 million suspended), where there were other bad things like fighting cancer claims and also nondisclosure by influencers like Cardi B. Certain procedural requirements: must be able to see & save a copy of the disclosures/contract w/in 15 days, via email receipt for example.